{
    "2018-07-30": [
        [
            {
                "time": "",
                "original_text": "华润双鹤销售费18亿是研发7倍 业绩不够竟然收购来凑",
                "features": {
                    "keywords": [
                        "华润双鹤",
                        "销售费",
                        "研发",
                        "收购"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药板块“半月惊魂”！股民惨遭“闷杀”后该怎么办？",
                "features": {
                    "keywords": [
                        "医药板块",
                        "半月惊魂",
                        "闷杀"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "320亿资金争夺20股：主力资金重点出击4股(名单)",
                "features": {
                    "keywords": [
                        "资金争夺",
                        "主力资金",
                        "出击",
                        "名单"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "美国药企高研发中国药企重销售，为何中国药企还能高盈利",
                "features": {
                    "keywords": [
                        "美国药企",
                        "研发",
                        "中国药企",
                        "销售",
                        "高盈利"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]医药生物行业研究周报：优选中报业绩优异标的 布局估值切换行情",
                "features": {
                    "keywords": [
                        "强于大市",
                        "医药生物",
                        "中报业绩",
                        "估值切换"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}